{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:54:32Z","timestamp":1790009672231,"version":"4.0.1"},"reference-count":20,"publisher":"Consilium Medicum","issue":"2","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Aim. To evaluate inflammatory cytokines, such as tumor necrosis factor \u03b1 (TNF-\u03b1), interleukin (IL)-1\u03b2, 8, 6, soluble IL-6 receptors (sIL-6R) and fragmented cytokeratin-18 (FCK-18) as indicators of non-alcoholic steatohepatitis (NASH).\r\nMaterials and methods. 173 NASH patients aged 47.0\u00b110.8 years were examined: 118 (68.2%) \u2013 men, 55 (31.8%) \u2013 women. The following markers were determined: TNF-\u03b1 (Human TNF\u03b1 Platinum ELISA, eBioscience, Austria), IL-1\u03b2, 8, 6 (Vector-Best, Russia), sIL-6R (Human sIL-6R ELISA, eBioscience, Austria), FCK-18 (TPS ELISA, Biotech, Sweden), insulin (Insulin TEST System, USA), HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) and NAFLD fibrosis score (NFS) were calculated.\r\nResults. The highest level in NASH patients compared with healthy individuals was observed for IL-6 \u2013 8.4\u00b11.6 pg\/ml versus 2.8\u00b10.9 pg\/ml (p=0.001), FCK-18 \u2013 295.3\u00b156.3 U\/l versus 110.5\u00b130.2 U\/l (p=0.0001), then IL-8 \u2013 17.3\u00b16.7 pg\/ml vs 7.6\u00b11.9 pg\/ml (p=0.003), TNF-\u03b1 \u2013 6.3\u00b10.4 pg\/ml versus 4.1\u00b10.8 pg\/ml (p=0.0001), sIL-6R \u2013 151.5\u00b121.2 ng\/ml vs 95.9\u00b112.5 ng\/ml (p0.05); IL-1\u03b2 did not change \u2013 5.3\u00b11.4 pg\/ml versus 4.7\u00b11.5 pg\/ml (p=0.3) respectively. FCK-18 showed the highest correlations with TNF-\u03b1 (r=0.73), HOMA-IR (r=0.73), alanine aminotransferase (r=0.71), erythrocyte sedimentation rate (r=0.23), IL-6 (r=0.22); p0.05. TNF-\u03b1 correlated with FCK-18 (r=0.73), cholesterol (r=0.61), albumin (r=-0.42), fibrinogen (r=0.21), leukocyte count (r=0.21); p0.05. IL-8 correlated with triglycerides (r=0.79) and HDL (r=-0.77), IL-6 \u2013 with NFS (r=0.63) and FCK-18 (r=0.22), rIL-6R \u2013 with aspartate aminotransferase (r=0.62); p0.05.\r\nConclusion. TNF-\u03b1, IL-8, 6, sIL-6R and FCK-18 should be used as non-invasive biomarkers of NASH.<\/jats:p>","DOI":"10.26442\/00403660.2025.02.203123","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T05:30:05Z","timestamp":1742967005000},"page":"115-120","source":"Crossref","is-referenced-by-count":2,"title":["Inflammatory cytokines, soluble interleukin-6 receptors, and fragmented cytokeratin-18 as indicators of non-alcoholic steatohepatitis"],"prefix":"10.26442","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3830-6446","authenticated-orcid":false,"given":"Anastasia A.","family":"Shipovskaya","sequence":"additional","affiliation":[{"name":"Petrozavodsk State University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2613-5694","authenticated-orcid":false,"given":"Olga P.","family":"Dudanova","sequence":"additional","affiliation":[{"name":"Petrozavodsk State University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7620-7065","authenticated-orcid":false,"given":"Irina V.","family":"Kurbatova","sequence":"additional","affiliation":[{"name":"Karelian Scientific Center of the Russian Academy of Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18344","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.22416\/1382-4376-2022-32-4-104-140"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.31146\/1682-8658-ecg-185-1-4-52"},{"key":"ref3","unstructured":"\u041a\u0440\u0438\u0432\u043e\u0448\u0435\u0435\u0432 \u0410.\u0411., \u0410\u0443\u0442\u0435\u043d\u0448\u043b\u044e\u0441 \u0410.\u0418., \u0411\u043e\u0439\u043a\u043e \u041a.\u042e., \u0438 \u0434\u0440. \u0426\u0438\u0442\u043e\u043a\u0438\u043d\u043e\u0432\u044b\u0439 \u0438 \u043f\u043e\u0440\u0444\u0438\u0440\u0438\u043d\u043e\u0432\u044b\u0439 \u0441\u043f\u0435\u043a\u0442\u0440\u044b \u0443 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u043d\u0435\u0430\u043b\u043a\u043e\u0433\u043e\u043b\u044c\u043d\u043e\u0439 \u0436\u0438\u0440\u043e\u0432\u043e\u0439 \u0431\u043e\u043b\u0435\u0437\u043d\u044c\u044e \u043f\u0435\u0447\u0435\u043d\u0438. \u042d\u043a\u0441\u043f\u0435\u0440\u0438\u043c\u0435\u043d\u0442\u0430\u043b\u044c\u043d\u0430\u044f \u0438 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0433\u0430\u0441\u0442\u0440\u043e\u044d\u043d\u0442\u0435\u0440\u043e\u043b\u043e\u0433\u0438\u044f. 2018;155(7): 37-42 [Krivosheev AB, Autenshlyus AI, Boyko KYu, et al. The cytokine and porphyrine spectrums in patients with non-alcoholic fatty lever disease. Experimental and Clinical Gastroenterology. 2018;155(7):37-42 (in Russian)]."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.01.025"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00473-x"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.47056\/0365-9615-2022-174-11-585-91"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23050"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1971"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238717"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28776"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708959"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114189"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.880298"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12621"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2021.00501"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228602"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a0363"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041774"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2013.28.1.41"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.123"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/312536\/193066","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/312536\/193066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:17:07Z","timestamp":1747225027000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/312536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,3,26]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2025.02.203123","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,26]]}}}